Cargando…
Frequent occurrence of T cell–mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments
BACKGROUND: Late allergic reactions are common in the course of allergen-specific immunotherapy and even occur with allergy vaccines with reduced IgE reactivity. OBJECTIVE: We sought to study atopy patch test (APT) reactions and T-cell responses to the recombinant birch pollen allergen Bet v 1 and r...
Autores principales: | Campana, Raffaela, Moritz, Katharina, Marth, Katharina, Neubauer, Angela, Huber, Hans, Henning, Rainer, Blatt, Katharina, Hoermann, Gregor, Brodie, Tess M., Kaider, Alexandra, Valent, Peter, Sallusto, Federica, Wöhrl, Stefan, Valenta, Rudolf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748398/ https://www.ncbi.nlm.nih.gov/pubmed/26518092 http://dx.doi.org/10.1016/j.jaci.2015.08.042 |
Ejemplares similares
-
Epicutaneous allergen application preferentially boosts specific T cell responses in sensitized patients
por: Campana, Raffaela, et al.
Publicado: (2017) -
Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial
por: Klimek, Ludger, et al.
Publicado: (2015) -
Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms
por: Campana, Raffaela, et al.
Publicado: (2018) -
Isolation of a high‐affinity Bet v 1‐specific IgG‐derived ScFv from a subject vaccinated with hypoallergenic Bet v 1 fragments
por: Gadermaier, E., et al.
Publicado: (2018) -
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy
por: Focke-Tejkl, Margarete, et al.
Publicado: (2015)